Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Condensed Consolidated Statements of Shareholders' Equity (Unaudited)

v3.21.2
Condensed Consolidated Statements of Shareholders' Equity (Unaudited) - USD ($)
$ in Thousands
Ordinary shares
Additional paid-in capital
Accumulated other comprehensive income
Accumulated deficit
Total
Balance at Dec. 31, 2019 $ 8,225 $ 103,401 $ 1,127 $ (110,311) $ 2,442
Balance (in Shares) at Dec. 31, 2019 120,652,683        
Net loss (8,235) (8,235)
Deemed dividends related to the warrants exercise 715 (715)
Issuance of share capital and warrants, net of issuance expenses of $ 3,126 $ 21,009 (6,159) 14,850
Issuance of share capital and warrants, net of issuance expenses of $ 3,126 (in Shares) 290,601,780        
Share-based payment   99 99
Balance at Jun. 30, 2020 $ 29,234 98,056 1,127 (119,261) 9,156
Balance (in Shares) at Jun. 30, 2020 411,254,463        
Balance at Dec. 31, 2020 $ 33,036 97,380 1,127 (125,469) 6,074
Balance (in Shares) at Dec. 31, 2020 463,769,463        
Issuance of share capital due to warrants exercise (Note 6a) $ 3,892 (1,148) 2,744
Issuance of share capital due to warrants exercise (Note 6a) (in Shares) 50,926,830        
Issuance of share capital in exchange for services (Note 6b) $ 80 (12) 68
Issuance of share capital in exchange for services (Note 6b) (in Shares) 1,050,000        
Net loss (5,097) (5,097)
Share-based payment 166 166
Balance at Jun. 30, 2021 $ 37,008 $ 96,386 $ 1,127 $ (130,566) $ 3,955
Balance (in Shares) at Jun. 30, 2021 515,746,293